Investigation of depression status in CAD patients

Authors

  • J. Mala Mahalakshmi Consultant Physician, Vivekanandha Medical Care Hospital, Tiruchengode, India
  • M. Rangapriya Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy. Tiruchengode – 637205, India
  • K. S. Ayshwariya Laxmi Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy. Tiruchengode – 637205, India
  • G. Ilakya Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy. Tiruchengode – 637205, India
  • Irene George Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy. Tiruchengode – 637205, India
  • Irine Jacob Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy. Tiruchengode – 637205, India

Keywords:

Beta blockers, Depression, CAD.

Abstract

Objective: The aim of the study was to investigate the depression status in the CAD patients who under the

beta blockers and HCN blocker therapy. Method: Prospective observational study for duration of 6 months

was carried out. Results: Patients treated with beta blocker therapy were less likely to experience depression

compared to other groups. Conclusion: Depression is highly prevalent among patients with CAD. Patients

treated with beta blocker therapy were less likely to experience depressive symptoms.

Dimensions

Published

2019-12-11

Issue

Vol. 9 No. 4 (2019): 2019 Volume -9 - Issue 4

Section

Articles
Copyright & Licensing
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.